Literature DB >> 15708101

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Herman Goossens1, Matus Ferech, Robert Vander Stichele, Monique Elseviers.   

Abstract

BACKGROUND: Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly recognised as the main selective pressure driving this resistance. Our aim was to assess outpatient use of antibiotics and the association with resistance.
METHODS: We investigated outpatient antibiotic use in 26 countries in Europe that provided internationally comparable distribution or reimbursement data, between Jan 1, 1997, and Dec 31, 2002, by calculating the number of defined daily doses (DDD) per 1000 inhabitants per day, according to WHO anatomic therapeutic chemical classification and DDD measurement methodology. We assessed the ecological association between antibiotic use and antibiotic resistance rates using Spearman's correlation coefficients.
FINDINGS: Prescription of antibiotics in primary care in Europe varied greatly; the highest rate was in France (32.2 DDD per 1000 inhabitants daily) and the lowest was in the Netherlands (10.0 DDD per 1000 inhabitants daily). We noted a shift from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. We also recorded striking seasonal fluctuations with heightened winter peaks in countries with high yearly use of antibiotics. We showed higher rates of antibiotic resistance in high consuming countries, probably related to the higher consumption in southern and eastern Europe than in northern Europe.
INTERPRETATION: These data might provide a useful method for assessing public-health strategies that aim to reduce antibiotic use and resistance levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708101     DOI: 10.1016/S0140-6736(05)17907-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  893 in total

1.  Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines.

Authors:  Claude Mambo Muvunyi; Florence Masaisa; Claude Bayingana; Léon Mutesa; André Musemakweri; Grégoire Muhirwa; Geert W Claeys
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Antibiotics in palliative medicine--results from a prospective epidemiological investigation from the HOPE survey.

Authors:  Stephanie Stiel; Norbert Krumm; Martina Pestinger; Gabriele Lindena; Friedemann Nauck; Christoph Ostgathe; Lukas Radbruch; Frank Elsner
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

3.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 4.  [Use of prescription drugs in Spain and Europe].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2011-10-22       Impact factor: 1.137

5.  [Variability in prescribing penicillins in the Segovia (Spain) Health Area].

Authors:  José María Pinilla Sánchez; José María Eiros Bouza; Elena Moreno Sánchez; Saturio Vega Quiroga
Journal:  Aten Primaria       Date:  2012-01-31       Impact factor: 1.137

6.  Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.

Authors:  Bingyun Li; Thomas J Webster
Journal:  J Orthop Res       Date:  2017-08-11       Impact factor: 3.494

7.  The quality of outpatient antimicrobial prescribing: a comparison between two areas of northern and southern Europe.

Authors:  Sara Malo; Lars Bjerrum; Cristina Feja; María Jesús Lallana; José María Abad; María José Rabanaque-Hernández
Journal:  Eur J Clin Pharmacol       Date:  2013-12-10       Impact factor: 2.953

8.  The knowledge mobilisation challenge: does producing evidence lead to its adoption within dentistry?

Authors:  T L Goodwin; P R Brocklehurst; L Williams
Journal:  Br Dent J       Date:  2018-02-02       Impact factor: 1.626

9. 

Authors:  María José Monedero Mira; Manuel Batalla Sales; Concepción García Domingo; María José Monedero Mira; Belén Persiva Saura; Gloria Rabanaque Mallen; Lledó Tárrega Porcar
Journal:  FMC       Date:  2016-04-26

10.  Exploring N-acylhydrazone derivatives against clinical resistant bacterial strains.

Authors:  Andressa C Lannes; Bruno Leal; Juliana S Novais; Viviane Lione; Georgia C T S Monteiro; André L Lourenço; Plínio C Sathler; Alessandro K Jordão; Carlos R Rodrigues; Lúcio M Cabral; Anna Claudia Cunha; Vinicius Campos; Vítor F Ferreira; Maria Cecília B V de Souza; Dilvani O Santos; Helena C Castro
Journal:  Curr Microbiol       Date:  2014-05-08       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.